Cite
HARVARD Citation
Nakajo, M. et al. (2020). The clinical value of PERCIST to predict tumour response and prognosis of patients with oesophageal cancer treated by neoadjuvant chemoradiotherapy. Clinical radiology. 75 (1), pp. 79.e9-79.e18. [Online].